MedAdvisor Past Earnings Performance
Past criteria checks 3/6
MedAdvisor has been growing earnings at an average annual rate of 7.5%, while the Healthcare Services industry saw earnings growing at 13% annually. Revenues have been growing at an average rate of 45.4% per year. MedAdvisor's return on equity is 1.5%, and it has net margins of 0.6%.
Key information
7.5%
Earnings growth rate
25.6%
EPS growth rate
| Healthcare Services Industry Growth | 42.6% |
| Revenue growth rate | 45.4% |
| Return on equity | 1.5% |
| Net Margin | 0.6% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Lacklustre Performance Is Driving MedAdvisor Limited's (ASX:MDR) Low P/S
Oct 23
Is MedAdvisor (ASX:MDR) Using Too Much Debt?
Jun 26Why Investors Shouldn't Be Surprised By MedAdvisor Limited's (ASX:MDR) Low P/S
Apr 24Are Investors Undervaluing MedAdvisor Limited (ASX:MDR) By 44%?
Mar 20Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?
Dec 15Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?
Apr 20MedAdvisor (ASX:MDR) Is Carrying A Fair Bit Of Debt
Jun 29Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now
Nov 09Is MedAdvisor (ASX:MDR) A Risky Investment?
Oct 11Is MedAdvisor (ASX:MDR) Using Too Much Debt?
Mar 08MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain
Feb 10What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?
Jan 18
The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares
Dec 22What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?
Dec 18Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation
Nov 22Revenue & Expenses Breakdown
How MedAdvisor makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 122 | 1 | 15 | 0 |
| 31 Mar 24 | 116 | -4 | 15 | 0 |
| 31 Dec 23 | 109 | -9 | 5 | 0 |
| 30 Sep 23 | 104 | -10 | 4 | 0 |
| 30 Jun 23 | 98 | -11 | 13 | 0 |
| 31 Mar 23 | 96 | -8 | 10 | 0 |
| 31 Dec 22 | 93 | -5 | 7 | 0 |
| 30 Sep 22 | 80 | -11 | 5 | 0 |
| 30 Jun 22 | 68 | -17 | 3 | 0 |
| 31 Mar 22 | 66 | -16 | 3 | 0 |
| 31 Dec 21 | 64 | -14 | 3 | 0 |
| 30 Sep 21 | 52 | -14 | 3 | 0 |
| 30 Jun 21 | 39 | -14 | 3 | 0 |
| 31 Mar 21 | 28 | -13 | 4 | 0 |
| 31 Dec 20 | 18 | -12 | 6 | 0 |
| 30 Sep 20 | 14 | -11 | 6 | 0 |
| 30 Jun 20 | 10 | -10 | 6 | 0 |
| 31 Mar 20 | 9 | -9 | 5 | 0 |
| 31 Dec 19 | 9 | -9 | 4 | 0 |
| 30 Sep 19 | 9 | -8 | 5 | 0 |
| 30 Jun 19 | 8 | -8 | 5 | 0 |
| 31 Mar 19 | 8 | -7 | 5 | 0 |
| 31 Dec 18 | 7 | -7 | 5 | 0 |
| 30 Sep 18 | 7 | -6 | 5 | 0 |
| 30 Jun 18 | 7 | -4 | 4 | 0 |
| 31 Mar 18 | 6 | -4 | 4 | 0 |
| 31 Dec 17 | 6 | -4 | 4 | 0 |
| 30 Sep 17 | 5 | -4 | 4 | 0 |
| 30 Jun 17 | 4 | -3 | 3 | 0 |
| 31 Mar 17 | 3 | -4 | 2 | 0 |
| 31 Dec 16 | 2 | -4 | 2 | 0 |
| 30 Sep 16 | 2 | -4 | 1 | 0 |
| 30 Jun 16 | 1 | -3 | 1 | 0 |
| 31 Mar 16 | 1 | -2 | 1 | 0 |
| 31 Dec 15 | 2 | -1 | 1 | 0 |
| 30 Sep 15 | 2 | -1 | 1 | 0 |
| 30 Jun 15 | 2 | -1 | 0 | 0 |
| 30 Jun 14 | 1 | -1 | 0 | 0 |
Quality Earnings: MDR has high quality earnings.
Growing Profit Margin: MDR became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MDR has become profitable over the past 5 years, growing earnings by 7.5% per year.
Accelerating Growth: MDR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MDR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare Services industry (12.7%).
Return on Equity
High ROE: MDR's Return on Equity (1.5%) is considered low.